
PGI's miracle of sound: Infant gets hearing gift with implant
2
3
Chandigarh: In a medical accomplishment that resonates with profound hope for families battling the silence of deafness, PGI Chandigarh has successfully performed an Auditory Brainstem Implant (ABI) on Abeer, a child barely 1.4 years old.
This makes him one of the youngest recipients of this life-altering procedure in India, offering a lifeline where conventional hearing solutions have failed. For Abeer's mother, Shilpa, it ignites a deeply personal hope of hearing her son utter a single word – 'ma' even if it takes years of waiting.
For Sumit and Shilpa, parents of little Abeer, life had been a silent, heart-wrenching struggle. "When Abeer was a year old, he just wasn't responding," recounts Shilpa, her voice still carrying the echoes of past pain.
A Brainstem Evoked Response Audiometry test at AIIMS Bathinda confirmed their deepest fears: profound deafness.
The devastating news was compounded when an MRI revealed Abeer's hearing nerve was tragically undeveloped, ruling out the more common cochlear implant. "We were heartbroken," Shilpa admits, recalling their desperate journey to Delhi, only to hit a dead end. Abeer's father, Sumit is a businessman based in Bathinda and has relocated to Chandigarh for Abeer's treatment.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Giao dịch CFD với công nghệ và tốc độ tốt hơn
IC Markets
Đăng ký
Undo
Hope, however, glimmered when Abeer was identified at PGI as a candidate for the highly specialised ABI. This groundbreaking procedure bypasses the non-functional cochlea and auditory nerves, directly stimulating the brainstem to interpret sound.
Prof Ramandeep Virk from the department of otolaryngology, the main surgeon for Abeer's case, said, "Abeer was born with Michels aplasia, a rare congenital malformation where inner ear structures are completely absent.
For children like Abeer, ABI is the only viable path to sound," adding that "the youngest in India to be treated was a child at the age of 1.39 years, in 2018 in Chennai."
While around 120 ABI surgeries have been performed across the country, most have taken place in private centres in Chennai, where the cost can soar to Rs 16-17 lakh for a single ear implant. At present, only Tamil Nadu government covers the expense of this surgery.
"We have had a word with the Haryana government on coverage for this surgery for our paediatric population here in the PGI. Two of our patients have been offered assistance from the state government, and we are hoping for more," said Prof Virk.
The surgery itself, independently performed by Prof Virk (ENT) and Dr Apinderpreet Singh (neurosurgery), presented immense challenges. "Operating on such a young child involves significant risks due to anaesthesia, potential blood loss, and delicate tissue handling," said Dr Ashwani Reddy, the anaesthesiologist involved in the case.
Post-operative care is equally critical, requiring vigilant monitoring in the ICU for at least 48 hours to prevent complications. "Yet, the younger the age, the better the outcomes for hearing, making early intervention paramount," emphasised Dr Parul Sud, the audiologist for the case.
The PGI team stressed that the journey ahead for Abeer is long as the implant in the brain has to be activated soon. "Unlike a cochlear implant, which sees learning within six months, an ABI works at the brain level, so learning takes much longer.
Therapies will continue for three to four years, requiring immense patience," said Prof Virk. He underscored the importance of parental commitment, stating, "We seek only motivated parents, as it's not about numbers, but sustainability – the dedication to years of therapy and follow-ups.
"
This achievement marks PGI's second successful ABI. Their first, performed in 2022 on a 2.5-year-old girl, involved a team including Prof Naresh Panda, Dr Mohan Kameshwaran, and Dr Vasu, who had flown from Chennai to assist. "Abeer's surgery was initially scheduled two months prior, but a crucial airport closure during the Pahalgam incident prevented the visiting pioneer, Prof Kameshwaran, from arriving; otherwise, Abeer could have been the country's absolute youngest at that time," said Prof Virk.
ABI can only be performed in children with inborn defects where the inner ear nerve connecting to the brain is missing. Those who have undergone a previous cochlear implant are not found suitable for the ABI.
Get the latest lifestyle updates on Times of India, along with
Doctor's Day 2025
,
messages
and quotes!
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Indian Express
30 minutes ago
- Indian Express
After probe report on financial irregularities, all but one clinical trials cancelled at Ahmedabad Hospital
When the investigation into the alleged financial irregularities in clinical trials at an Ahmedabad-based government hospital began, 10 trials were underway at the hospital while seven, for which agreements had been signed, were yet to begin. With the irregularities coming to light, all the clinical trials that were in their initial phases were shut down, while those that were yet to begin were cancelled, said a senior official of the Ahmedabad Municipal Corporation (AMC). As of now, only one clinical trial is underway at the Sheth Vadilal Sarabhai General Hospital, Medical Superintendent Dr Parul Shah confirmed with The Indian Express. Meanwhile, at least four to five doctors accused in the scam have returned the amount deposited in their bank accounts, said Dr Shah. 'We have sent the doctors notices that as per the report, we need to recover the money they received directly for the clinical trials. At least 4-5 doctors have already paid back the amount. The rest are also going to pay us back,' said Dr Shah. When asked if the hospital would conduct more trials in the coming days, an official said, 'We have decided to not do any clinical trials at the moment till all these irregularities are sorted out.' As reported by The Indian Express on July 1, a probe panel in Gujarat found financial irregularities in about 65 human clinical trials conducted at the hospital run by the AMC, where 15 doctors allegedly diverted at least Rs 1.87 crore directly to their personal accounts from 2021 — money that should have gone to the hospital first, according to a senior official. It has now also been learnt that the Drugs Controller General of India (DCGI) has asked the hospital not to conduct any more trials without proper standard operating procedures and permissions. The clinical trials that the hospital was conducting included those of drugs and formulations from 34 different pharmaceutical companies and clinical research companies (CROs), and were being managed by up to eight Site Management Organisations (SMOs). Of the 65 trials, a total of 48 had been completed, 10 were underway and seven were yet to begin, for which agreements had been signed. However, according to hospital officials, currently, only one trial is still underway. An official from the AMC Medical Education Trust (AMCMET) said, 'We had stopped most of the clinical trials that were in their initial phases before the investigation began. Only one trial is underway and we will complete that trial in the interest of the patients. No patients have had to suffer due to the financial irregularities.' Dr Shah said, 'The DCGI team that conducted its investigation here at the hospital said that the clinical trials themselves were conducted in a proper manner. Whatever discrepancies were there, were in the financial aspects. The trials were not compromised.' The DCGI, when it conducted its three-day investigation in May, asked the hospital to immediately stop the trials, form an ethics committee and get it vetted by the authorities if they wanted to conduct more trials, said sources. A total of 15 doctors were alleged to have siphoned off Rs 1.87 crore, proceeds from 58 clinical trials, into their personal bank accounts. Only Rs 10.63 lakh had been found to have been deposited in the account of the hospital. An inquiry committee found that a retired Medical Superintendent, an Associate Professor and 12 contractual doctors had been involved in the alleged scam


Time of India
an hour ago
- Time of India
What does the brain do in sleep? 5 amazing tasks it carries out every night
Every night while our body is resting, the brain is still working hard in many ways. While sleep for the body might just mean rest, for the brain, it is the time to build up on your immunity and go into "repair mode" . Let's explore the amazing things the brain does while we catch up on our beauty sleep every night. Discards waste One of the most important jobs your brain does during sleep is cleaning out waste, just like you do it everyday at your home. Throughout the day, your brain cells produce waste products as they work. If these wastes build up overtime, they can cause problems like memory loss or brain diseases. Hence, it is important to discard the waste on an everyday basis. During sleep, a special cleaning system called the glymphatic system becomes active. It uses cerebrospinal fluid to flush out toxins and harmful proteins from the brain. Think of it as a nightly brain wash that helps keep your brain healthy and working well. Hence, getting good quality sleep, night after night may lower the risk of diseases like Alzheimer's, which is linked to the buildup of harmful proteins in the brain. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với sàn môi giới tin cậy IC Markets Tìm hiểu thêm Undo Sorting and storing Sleep plays a key role in helping your brain remember things. When you learn something new during the day, or even a new skill, your brain needs time to process and store that information and helps you retain it. During sleep, especially during a stage called REM (Rapid Eye Movement) sleep, your brain sorts through the memories you made during the day. It decides which memories to keep and which ones to discard. (imagine remembering how difficult it would be to remember everything about your life!) Important memories get strengthened and moved from short-term storage to long-term storage. (such as the day of your wedding, or the day when you lost a loved one) This is why a good night's sleep can help you do better in school or work, because your brain has had time to organize and save what you learned. Recharge and rejuvenate Even though the brain never fully 'turns off,' it uses less energy during sleep. Sleep gives your brain a chance to recharge and restore energy so it can work well the next day, and the day after that, and so on. During deep sleep, brain activity slows down, and the brain cells get a break from their busy schedule. This rest helps repair cells and supports the growth of new brain cells and connections. Think of it like charging your phone battery overnight—your brain needs that recharge to stay sharp, focused, and alert to do it all again the next day! Regulates Emotions and Mood Sleep helps the brain manage emotions and mood. When you don't get enough sleep, you might feel more irritable, stressed, or anxious, or even physically sick! That's because sleep affects the parts of the brain that control emotions. During sleep, especially REM sleep, the brain processes emotional experiences and helps reduce emotional stress. It also strengthens the brain's ability to handle difficult feelings and improves emotional resilience, and strength. This is why good sleep is important for mental health. It can help reduce the risk of depression, anxiety, and mood disorders. Supports Learning and Creativity Sleep is a powerful tool for boosting creativity and problem-solving skills. When you sleep, your brain connects ideas and information in new ways, helping you come up with creative solutions. During REM sleep, the brain is especially active, almost like it's dreaming up new ideas. This stage helps your brain make unexpected connections between memories and knowledge. Many people find that after a good night's sleep, they can think more clearly and solve problems better (which is why it is said to revise in the morning before an exam or a presentation) . That's because the brain has had time to work behind the scenes while you were asleep. Sources Medical News Today The Proceedings of the National Academy of Sciences (PNAS) The National Institute of Neurological Disorders and Stroke (NINDS)


India Today
2 hours ago
- India Today
Same pills, smaller bills: Janaushadhi means savings
As Bihar moves closer to state elections, a strategic shift is underway in its rural healthcare approach, merging policy rollout with political March, the Centre announced that Primary Agricultural Credit Societies across India would operate Janaushadhi Kendras to expand access to affordable generic medicines. Bihar has now joined the ahead of the elections, the Muzaffarpur district administration selected seven PACS to open Janaushadhi outlets in its first phase, with one already licensed and six more in the These centres will make World Health Organisation-certified generic medicines available at prices 50–80 per cent lower than branded alternatives, making essential healthcare more affordable for rural of March 2025, more than 2,300 PACS across 34 states and Union Territories had been approved to operate Janaushadhi Kendras, raising key questions: how evenly are these centres distributed across India, and how much can people save?More kendras, more savingsAs of February 2025, the number of Janaushadhi Kendras operating across the country stood at 16,489, more than doubling from 6,306 outlets in 2019– consistent growth in presence has also led to a sharp rise in sales and consumer savings. In 2019–20, the scheme reported sales of Rs 433.61 crore with citizen savings estimated at Rs 2,500 crore. The following year, 2020–21, saw the number of kendras grow to 7,557, sales jump to Rs 665.83 crore, and estimated savings touch Rs 4,000 crore according to the Janaushadhi annual upward trend continued in 2021–22, with 8,610 kendras and Rs 5,400 crore in savings. By 2023–24, the number of centres increased to 12,616, through which people saved Rs 7,350 of the PriceMedicines that typically cost hundreds or thousands are available at a fraction of the price under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. A price comparison across ten commonly used medicines and medical items shows just how significant the savings can instance, Glibenclamide, a common diabetes drug, is sold for just Rs 5.5 per strip under the scheme, compared to Rs 30 in regular pharmacies, offering a saving of around 82 per cent. A pulse oximeter, often used in respiratory care, an important machine after Covid-19, costs Rs 495 through Janaushadhi but sells for nearly Rs 1,599 in retail, a 69 per cent price cut. Budesonide inhalers used by asthma patients are available for Rs 123 compared to the market average of Rs acetate injections, often prescribed for prostate and breast cancer, cost Rs 1,800 under the scheme, down from the market price of Rs 3,453, a 48 per cent saving. Other drugs show a similar trend. The price gap spans across multiple therapeutic areas: diabetes, oncology, cardiovascular disease, respiratory care, and even surgical consumables, and offers a wide range of 2,047 generic medicines and 300 surgical items, all priced 50 per cent to 80 per cent lower than their branded counterparts.- Ends